Press Releases
  • LifeMine Therapeutics Appoints Elliot Ehrich, M.D., as Chief Medical Officer and EVP of Translational Science and Lata Jayaraman, Ph.D., as EVP, Head of Biology
  • LifeMine Therapeutics Appoints Jennifer A. Jarrett to Board of Directors
  • LifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC
  • Fierce Biotech names LifeMine Therapeutics as one of its “Fierce 15” Biotech Companies of 2022
    September 12, 2022
Load More Load More

We are pushing the boundaries of science to explore an uncharted terrain of drug discovery.